Cytek Biosciences (CTKB) Long-Term Deferred Tax (2020 - 2025)
Cytek Biosciences' (CTKB) quarterly Long-Term Deferred Tax came in at $38.4 million in Q3 2025, up 24.74% YoY from $30.8 million in Q3 2024, and up 7.35% on a QoQ basis from $35.8 million in Q2 2025.
Cytek Biosciences (CTKB) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends
Cytek Biosciences (CTKB) has 6 years of Long-Term Deferred Tax data on file, last reported at $38.4 million in Q3 2025.
- Quarterly Long-Term Deferred Tax rose 24.74% year-over-year to $38.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $38.4 million (up 24.74% YoY) and the FY2024 annual result came in at $33.4 million, up 9.47% from the prior year.
- Long-Term Deferred Tax climbed to $38.4 million in Q3 2025, from $35.8 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $38.4 million in Q3 2025 to a low of $7.4 million in Q2 2021.
- A 5-year average of $23.3 million and a median of $25.2 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax surged 125.74% — and 2025, when it increased 3.06%.
- Tracing CTKB's Long-Term Deferred Tax over 5 years: stood at $9.2 million in 2021, then jumped by 123.03% to $20.5 million in 2022, then soared by 49.02% to $30.5 million in 2023, then rose by 9.47% to $33.4 million in 2024, then increased by 15.04% to $38.4 million in 2025.
- The last three Long-Term Deferred Tax figures came in at $38.4 million (Q3 2025), $35.8 million (Q2 2025), and $33.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 602.64 Mn | 528.79 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 38.39 Mn |
| Jun 30, 2025 | 35.77 Mn |
| Mar 31, 2025 | 33.71 Mn |
| Dec 31, 2024 | 33.37 Mn |
| Sep 30, 2024 | 30.78 Mn |
| Jun 30, 2024 | 29.68 Mn |
| Mar 31, 2024 | 32.71 Mn |
| Dec 31, 2023 | 30.49 Mn |
| Sep 30, 2023 | 24.08 Mn |
| Jun 30, 2023 | 26.39 Mn |
| Mar 31, 2023 | 23.40 Mn |
| Dec 31, 2022 | 20.46 Mn |
| Sep 30, 2022 | 13.99 Mn |
| Jun 30, 2022 | 11.69 Mn |
| Mar 31, 2022 | 10.69 Mn |
| Dec 31, 2021 | 9.17 Mn |
| Sep 30, 2021 | 7.38 Mn |
| Jun 30, 2021 | 7.38 Mn |
| Dec 31, 2020 | 7.38 Mn |